Approval · Notice of Compliance 14658 · 2013
RENAGEL: Notice of Compliance 14658
Issued August 15, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14658
- Date
- August 15, 2013
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administraive transfer of drug identification number
- Therapeutic class
- Phosphate binder
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RENAGEL | 02244310 | Marketed |
Medicinal ingredients
- SEVELAMER HYDROCHLORIDE 800 MG per TAB